Dr. Philip J. Stella
Claim this profileSaint Joseph Mercy Hospital
Expert in Cancer
Expert in Lung Cancer
38 reported clinical trials
89 drugs studied
About Philip J. Stella
Education:
- Received MD from Michigan State University's College of Human Medicine, East Lansing, Michigan.
Experience:
- Completed residency at St. Joseph Mercy Hospital, Ann Arbor, Michigan.
- Serves as Medical Director of the cancer care program at St. Joseph Mercy Hospital.
- Founded and leads the Michigan Cancer Research Consortium (MCRC).
- Developed a $13 million free-standing cancer center in Brighton, Michigan.
- Collaborates with University of Michigan and Karmanos Cancer Institute for comprehensive cancer care.
Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Philip J. Stella is currently running
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
Digital Tomosynthesis vs. Standard Mammography
for Breast Cancer Screening
This randomized phase III trial studies digital tomosynthesis mammography and digital mammography in screening patients for breast cancer. Screening for breast cancer with tomosynthesis mammography may be superior to digital mammography for breast cancer screening and may help reduce the need for additional imaging or treatment.
Recruiting2 awards Phase 34 criteria
More about Philip J. Stella
Clinical Trial Related5 years of experience running clinical trials · Led 38 trials as a Principal Investigator · 17 Active Clinical TrialsTreatments Philip J. Stella has experience with
- Pembrolizumab
- Nivolumab
- Carboplatin
- Olaparib
- Pemetrexed
- Surgery
Breakdown of trials Philip J. Stella has run
Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Philip J. Stella specialize in?
Philip J. Stella focuses on Cancer and Lung Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Philip J. Stella currently recruiting for clinical trials?
Yes, Philip J. Stella is currently recruiting for 15 clinical trials in Ann Arbor Michigan. If you're interested in participating, you should apply.
Are there any treatments that Philip J. Stella has studied deeply?
Yes, Philip J. Stella has studied treatments such as Pembrolizumab, Nivolumab, Carboplatin.
What is the best way to schedule an appointment with Philip J. Stella?
Apply for one of the trials that Philip J. Stella is conducting.
What is the office address of Philip J. Stella?
The office of Philip J. Stella is located at: Saint Joseph Mercy Hospital, Ann Arbor, Michigan 48197 United States. This is the address for their practice at the Saint Joseph Mercy Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.